Haemonetics Introduces Next Generation "Intelligent Control" Software for Cell Saver® Elite®+ Autotransfusion System

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) has received 510(k) clearance from the U.S. Food and Drug Administration for its next-generation Intelligent Control software for the Cell Saver Elite+ Autotransfusion System. This upgrade includes over 50 automation enhancements aimed at improving efficiency and user experience. The Cell Saver technology allows hospitals to recover patients' blood during surgeries, helping prevent unnecessary transfusions. The software upgrade enhances versatility, offering features such as Manual Mode and optimized wash volumes according to industry standards.

Positive

• Received 510(k) clearance from FDA for Intelligent Control software.
• Software offers over 50 automation enhancements.
• Enhances user experience and operational efficiency.
• Supports recovery of patients' blood, reducing transfusion costs.

Negative

• None.

BOSTON, March 2, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on the next-generation software for the Cell Saver^® Elite^®+ Autotransfusion System, with full market release available now. This software upgrade, named Intelligent Control, offers customers key enhancements to help simplify operations, supporting enhanced efficiency and an improved user experience.

The Cell Saver Elite+ Autotransfusion System is state-of-the-art technology that gives hospitals the ability to recover a patient's own blood in surgical procedures with the potential for medium to high blood loss, helping to avoid unnecessary allogeneic transfusions while reducing related costs. The new Intelligent Control software provides more than 50 automation enhancements to augment the user experience, including complete user control with a "Manual Mode" option, expanded wash volumes adjustable to the Association for the Advancement of Blood & Biotherapies (AABB) recommended levels, and enhanced Emergency Options.

"This latest upgrade represents a significant advancement in our Cell Salvage platform and builds upon our nearly 50-year foundation as the leader in autotransfusion. The Intelligent Control software enhances our SmartSuction^® and Latham bowl technologies to help maximize the recovery of red blood cells," said Stewart Strong, President of Global Hospital at Haemonetics. "With the new software for the Cell Saver Elite+, we are delivering customers more versatility and simplicity to best meet their autotransfusion needs."

For more information about the Cell Saver Elite+ system, please go to

hospital.haemonetics.com/cell-salvage/cell-saver-elite-plus.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Sr. Director-Investor Relations & Treasury 
(781) 356-9763
olga.guyette@haemonetics.com

David Trenk, Manager-Investor Relations 
(203) 733-4987
david.trenk@haemonetics.com

Media Contact:
Josh Gitelson, Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-introduces-next-generation-intelligent-control-software-for-cell-saver-elite-autotransfusion-system-301760781.html

SOURCE Haemonetics Corporation

FAQ

What is the new software released by Haemonetics for the Cell Saver Elite?

The new software is called Intelligent Control, featuring over 50 automation enhancements.

When did Haemonetics announce the FDA clearance for the Cell Saver Elite?

Haemonetics announced the FDA clearance on March 2, 2023.

What are the benefits of the Cell Saver Elite+ Autotransfusion System?

The system allows hospitals to recover a patient's blood during surgery, avoiding unnecessary transfusions and reducing related costs.

How does Intelligent Control improve the Cell Saver system?

It enhances user experience with features like Manual Mode and optimized wash volumes.

What does 510(k) clearance mean for Haemonetics?

It indicates the FDA has deemed the software safe and effective for market use.